Table 5.
Ring A | Ring B | hSUCNR1 | mSUCNR1 | ClogPb | |
---|---|---|---|---|---|
pEC50 (efficacy, %)a | |||||
28 | 6.79 ± 0.12 (58.0 ± 2.7) | 5.92 ± 0.09 (64.0 ± 2.5) | 2.01 | ||
29 | 6.85 ± 0.19 (52.6 ± 3.9) | 6.74 ± 0.13 (71.2 ± 3.2) | 1.07 | ||
30 | 7.23 ± 0.14 (49.2 ± 2.7) | 5.84 ± 0.16 (45.3 ± 3.4) | 3.11 | ||
31 | 7.64 ± 0.13 (61.7 ± 2.5) | 6.75 ± 0.09 (69.9 ± 2.2) | 2.18 | ||
32 | 7.23 ± 0.23 (88.7 ± 6.1) | 7.00 ± 0.09 (68.1 ± 2.5) | 1.86 | ||
33 | 7.23 ± 0.37 (66.4 ± 7.2) | 7.29 ± 0.18 (61.5 ± 3.8) | 2.13 |
apEC50 values were determined from dose-response curves of induction of IP3 turnover in SUCNR1 transfected HEK cells (N = 3), efficacy is determined relative to succinate (100%). bCalculated by BioByte’s algorithm as implemented in ChemDraw Professional 16.0.1.4 (ClogP option).